Variable P HR 95%CI  
Sexe (F vs. M) 0.796 1.200 0.318-3.763
Age des patients (<60 vs≥60) 0.854 0.902 0.300-2.713         
Grade(low vs. high) 0.991 1.005 0.421-2.398
Stage (T1 vs. Ta) 0.641 0.791 0.296-2.118
Tumor size(<3 vs≥3) 0.952 0.972 0.377-2.505
Multiplicity 0.504 1.358 0.554-3.331
HSP90 (low vs. high) 0.884 1.096 0.319-3.768
Abbreviations: HR: Hazard ratio; 95% CI: Confidence Interval; p< 0.05 is significant.
Table 3: Multivariate analysis of disease recurrence in patient with NMIBC treated by BCG immunotherapy.